Effects of the Contraceptive Implant in Women With Sickle Cell Disease

NCT05730205 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DRUG: Nexplanon 68 MG Drug Implant

Sponsor

University of Pennsylvania